Defender Capital LLC. Grows Stock Holdings in Danaher Corporation $DHR

Defender Capital LLC. grew its stake in Danaher Corporation (NYSE:DHR) by 0.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 157,041 shares of the conglomerate’s stock after purchasing an additional 498 shares during the period. Danaher makes up approximately 10.5% of Defender Capital LLC.’s holdings, making the stock its 4th largest holding. Defender Capital LLC.’s holdings in Danaher were worth $31,022,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. GHP Investment Advisors Inc. grew its position in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 99 shares during the last quarter. Sierra Ocean LLC grew its position in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 76 shares during the last quarter. Red Tortoise LLC grew its position in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after acquiring an additional 98 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in Danaher during the 1st quarter worth approximately $31,000. Finally, Dunhill Financial LLC grew its position in Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 67 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Danaher Stock Performance

DHR stock opened at $205.36 on Tuesday. The business’s fifty day moving average is $200.82 and its 200-day moving average is $197.06. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The company has a market cap of $147.05 billion, a P/E ratio of 43.69, a price-to-earnings-growth ratio of 2.88 and a beta of 0.77. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.41.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm’s quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. Danaher’s dividend payout ratio is 27.23%.

Wall Street Analyst Weigh In

A number of research firms recently commented on DHR. Redburn Partners set a $220.00 price target on Danaher in a research report on Wednesday, October 8th. Guggenheim restated a “buy” rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, July 23rd. Barclays reiterated an “overweight” rating and issued a $225.00 price objective (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a research report on Wednesday, October 8th. Finally, Evercore ISI increased their price objective on Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a research report on Tuesday, October 7th. Seventeen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $244.60.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.20% of the stock is currently owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.